Sofinnova Closes $312M 7th Fund; Bets on Life Sciences
By Cormac Sheridan
Tuesday, December 11, 2012
Europe's cash-starved biotechnology sector has another €240 million (US$312 million) to aim for, following Sofinnova Partners' successful closing of its seventh fund.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.